1402452-15-6

基本信息
hSMG-1 inhibitor 11j
Pyrimidine Related Compound 1
2-Chloro-N,N-diethyl-5-[[4-[2-[4-[[(MethylaMino)carbonyl]aMino]phenyl]-4-pyridinyl]-2-pyriMidinyl]aMino]benzenesulfonaMide
Benzenesulfonamide, 2-chloro-N,N-diethyl-5-[[4-[2-[4-[[(methylamino)carbonyl]amino]phenyl]-4-pyridinyl]-2-pyrimidinyl]amino]-
物理化學(xué)性質(zhì)
報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
2025/05/22 | HY-124719 | 嘧啶雜質(zhì)1 hSMG-1 inhibitor 11j | 1402452-15-6 | 1 mg | 1700元 |
2025/05/22 | HY-124719 | 嘧啶雜質(zhì)1 hSMG-1 inhibitor 11j | 1402452-15-6 | 5mg | 4000元 |
2025/05/22 | HY-124719 | 嘧啶雜質(zhì)1 hSMG-1 inhibitor 11j | 1402452-15-6 | 10 mM * 1 mLin DMSO | 4981元 |
常見問題列表
hSMG-1 0.11 nM (IC 50 ) |
mTOR 50 nM (IC 50 ) |
PI3Kγ 60 nM (IC 50 ) |
PI3Kα 92 nM (IC 50 ) |
GSKα 260 (IC 50 ) |
GSKβ 330 (IC 50 ) |
CDK2 7.1 μM (IC 50 ) |
CDK1 32 μM (IC 50 ) |
hSMG-1 inhibitor 11j (0.3-3 μM; 6 h) significantly reduces UPF1 phosphorylation at 0.3 μM, and eliminates it at 1 μM in MDA 361 cells.
hSMG-1 inhibitor 11j inhibits MDA468 cell proliferation, with an IC
50
of 75 nM.